Patent details
EP3654983 Title: MPO INHIBITORS FOR USE IN MEDICINE
Basic Information
- Publication number:
- EP3654983
- PCT Application Number:
- EP2018068992
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP187402086
- PCT Publication Number:
- WO2019016074
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- MPO INHIBITORS FOR USE IN MEDICINE
- French Title of Invention:
- INHIBITEURS DE LA MPO DESTINÉS À ÊTRE UTILISÉS EN MÉDECINE
- German Title of Invention:
- MPO-INHIBITOREN ZUR VERWENDUNG IN DER MEDIZIN
- SPC Number:
Dates
- Filing date:
- 12/07/2018
- Grant date:
- 30/08/2023
- EP Publication Date:
- 27/05/2020
- PCT Publication Date:
- 24/01/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/08/2023
- EP B1 Publication Date:
- 30/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/07/2024
- Expiration date:
- 12/07/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/08/2023
- Name:
- Astrazeneca AB
- Address:
- ., 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- WHITTAKER, Andrew
- Address:
- United Kingdom (GB)
2
- Name:
- SANGANEE, Hitesh, Jayantilal
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 201762533448 P
- Priority Date:
- 17/07/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/505; A61P 15/10;
Publication
European Patent Bulletin
- Issue number:
- 202335
- Publication date:
- 30/08/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|